期刊文献+

艾拉莫德混悬剂的制备及稳定性考察 被引量:1

Preparation of suspension of Iguratimod and studies on the physical stability
下载PDF
导出
摘要 目的制备艾拉莫德纳米混悬剂并对其物理稳定性进行考察。方法考察助悬剂的性质(密度,流变特性),以沉降体积比和再分散性为评价指标对制得的混悬剂进行评价。结果卡波沫和羧甲基纤维素钠助悬效果较好。结论选取合适的助悬剂可制得物理稳定性良好的艾拉莫德纳米混悬剂。 Objective: To prepare the suspension of iguratimod and to observe the physical stability. Methods: The property of the suspending agents ( density, rheology) was investigated. The sedimentation rate and redispersion were used to avaluate the property of suspension Physical stability. Results: Carbopol and cmc-Na had good property for preparing suspension. Conclusion: The suspension of iguratimod with good physical stability can be made with suspending agent carbopol and cmc-Na.
作者 宋明侠
出处 《泰山医学院学报》 CAS 2009年第7期490-492,共3页 Journal of Taishan Medical College
关键词 艾拉莫德 纳米混悬剂 物理稳定性 iguratimod suspension physical stability
  • 相关文献

参考文献4

二级参考文献21

  • 1朱建芬,吴祥根.纳米混悬剂的制备方法及在药剂学中应用的研究进展[J].中国医药工业杂志,2006,37(3):196-200. 被引量:38
  • 2RH Muller, R Becker, B Kruss, et al. Pharmaceutical nanosuspensions for medicament administration as systems with increased saturation solubility and rate of solution[P]. United States Patent 5,858,410, Medac Geseitschaft far Klinische Spezialpraparate mbH, 1999.
  • 3Claudia Jacobs, Rainer Helmut Muller. Production and characterization of a budesonide nanosuspension for pulmonary administration[J]. Pharm Res, 2002,19(2): 189-194.
  • 4C Jacobs, O Kayser, RH Mfiller. Nanosuspensions as a new approach for the formulation for the poorly soluble drug tarazepide[J]. Int J Pharm, 2000, 196(2) : 161-164.
  • 5K Peters, S Leitzke, JE Diederichs, et al. Preparation of a clofazimine nanosuspension for intravenous use and evaluation of its therapeutic efficacy in murine Mycobacterium avium infection[J]. J Antimicrob Chemother, 2000, 45 (1) : 77-83.
  • 6KP Krause, O Kayser, K Mader, et al. Heavy metal contamination of nanosuspensions produced by high-pressure homogenisation[J]. Int J Pharrn,2000,196(2) : 169-172.
  • 7JE Kipp, Wong, JCT, et al. Microprecipitation Method For Preparing Submieron Suspensions[P]. United States Patent 6,607,784, Baxter International Inc. (Deerfield, IL), USA, 2003.
  • 8Henriksen, Mishra, Pace, et al. Insoluble drug delievery[P], International Patent 97/14407, Triangle Pharmaceuticals, The university of Texas system, April 24,1997.
  • 9James E. Kipp, Mark J. Doty,CL. Rebbeck, etal. Compositions of and Method for Preparing Stable Partieiles in a Frozen Aqueous Matrix[P], United States Patent 7,112,340, Baxter International Inc. (Deerfield, IL) Sep. 26, 2006.
  • 10Vergnauh,Grenier, Nhamias, et al. Method for The Preparation of Pharmaceutical Nanosuspensions Using Supersonic Fluid Flow[P]. Ep Patent WO 03/045353, June 5, 2003.

共引文献29

同被引文献8

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部